BRIEF published on 03/13/2025 at 12:43, 1 year 1 month ago Franchissement de Seuil par JP Morgan dans ABIVAX Droits De Vote Franchissement De Seuil Actions Abivax JP Morgan
BRIEF published on 03/13/2025 at 12:43, 1 year 1 month ago JP Morgan Crosses Threshold in ABIVAX Voting Rights Actions Abivax Threshold Crossing JP Morgan
PRESS RELEASE published on 03/13/2025 at 12:38, 1 year 1 month ago Franchissement de seuil JP Morgan Chase & Co. déclare avoir franchi 5% du capital d'ABIVAX le 28 février 2025. Détention indirecte via J.P. Morgan Securities plc et J.P. Morgan Securities LLC Déclaration Franchissement De Seuil Abivax JP Morgan J.P. Morgan Securities
BRIEF published on 02/25/2025 at 18:05, 1 year 2 months ago ABIVAX : Informations sur le capital et les droits de vote au 31 janvier 2025 Euronext Paris Droits De Vote Capital Social Abivax Finances
BRIEF published on 02/25/2025 at 18:05, 1 year 2 months ago ABIVAX: Information on capital and voting rights as of January 31, 2025 Euronext Paris Share Capital Voting Rights Abivax Finances
PRESS RELEASE published on 02/25/2025 at 18:00, 1 year 2 months ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.25. ABIVAX communique le nombre d'actions composant son capital social et le nombre total de droits de vote au 31.01.25 conformément aux réglementations en vigueur Droits De Vote Capital Social Abivax Réglementation Communication
BRIEF published on 02/21/2025 at 08:35, 1 year 2 months ago Abivax to Hold Expert Webcast on Ulcerative Colitis Abivax Obefazimod Ulcerative Colitis Clinical Trial Webcast Event
BRIEF published on 02/21/2025 at 08:35, 1 year 2 months ago Abivax organise un webcast d'experts sur la rectocolite hémorragique Abivax Obefazimod Rectocolite Hémorragique Essai Clinique Webcast De L'événement
PRESS RELEASE published on 02/21/2025 at 08:30, 1 year 2 months ago Abivax organisera un webcast animé par un leader d’opinion de renom le 17 mars 2025 Abivax organise un webcast le 17 mars 2025 animé par le Dr David Rubin, expert en gastro-entérologie, pour présenter l'essai clinique de phase 3 ABTECT sur la rectocolite hémorragique Abivax Webcast Rectocolite Hémorragique Essai Clinique Dr David Rubin
PRESS RELEASE published on 02/21/2025 at 08:30, 1 year 2 months ago Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025 Abivax to host Key Opinion Leader (KOL) webcast featuring Dr. David Rubin on March 17, 2025, discussing ulcerative colitis treatment landscape and ABTECT Phase 3 Trial Abivax Ulcerative Colitis Webcast ABTECT Phase 3 Trial Key Opinion Leader
Published on 05/08/2026 at 01:50, 2 hours 26 minutes ago Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 3 hours 31 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 4 hours 16 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 4 hours 46 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 5 hours 1 minute ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 23:23, 4 hours 52 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 5 hours 2 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 6 hours 11 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 7 hours 34 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 9 hours 30 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 9 hours 1 minute ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 9 hours 1 minute ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 9 hours 10 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 9 hours 10 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 9 hours 16 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
